Sjögren Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

Deucravacitinib in Adults With Active Sjögren's Syndrome
Sorry, not currently recruiting here
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
San Francisco, California and other locations

Last updated: October 30, 2024